Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function

Anna G Dagre1, John P Lekakis, Athanassios D Protogerou

  • 1Vascular Laboratory, Department of Clinical Therapeutics, Alexandra University Hospital, 23 Ikarias Street, 14578 Ekali, Athens, Greece. annadagre@hotmail.com

Insights

Hypothyroidism is linked to endothelial dysfunction, impacting blood vessel health. Treatment for hypothyroidism normalizes this function, suggesting a role in cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Vascular Biology

Background:

  • Hypothyroidism is a potential risk factor for cardiovascular disease.
  • Endothelial function is crucial for vascular health and NO-dependent vasodilation.
  • Assessing endothelial function in hypothyroidism can elucidate cardiovascular risk pathways.

Purpose of the Study:

  • To evaluate nitric oxide-dependent endothelial function in resistance arteries of individuals with varying degrees of hypothyroidism.
  • To investigate the relationship between thyroid-stimulating hormone (TSH) levels and endothelial function.
  • To determine if L-thyroxine therapy improves endothelial function in hypothyroidism.

Main Methods:

  • Ninety-six female subjects were categorized into five groups based on TSH levels, including controls, upper normal TSH, subclinical hypothyroidism, overt hypothyroidism, and treated hypothyroidism.
  • Forearm blood flow response during reactive hyperemia was measured using venous occlusion strain-gauge plethysmography to assess endothelial function.
  • Statistical analysis, including ANOVA, was employed to compare groups and assess correlations.

Main Results:

  • Duration of reactive hyperemia, a measure of endothelial function, significantly differed among the hypothyroidism groups (p<0.001).
  • Endothelial function was impaired in subjects with upper normal TSH and subclinical hypothyroidism compared to controls, and significantly worse in overt hypothyroidism.
  • A significant negative linear correlation was observed between duration of reactive hyperemia and TSH levels (r=-0.383, p<0.001).

Conclusions:

  • Endothelial dysfunction is present in the microvasculature of patients with hypothyroidism, worsening with increased TSH levels.
  • This endothelial dysfunction may contribute to the increased cardiovascular disease risk associated with hypothyroidism.
  • Effective L-thyroxine therapy for hypothyroidism appears to restore normal endothelial function.
Abstract

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...